PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RGEN vs. USA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RGEN and USA is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

RGEN vs. USA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Repligen Corporation (RGEN) and Liberty All-Star Equity Fund (USA). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-9.10%
10.25%
RGEN
USA

Key characteristics

Sharpe Ratio

RGEN:

-0.61

USA:

1.25

Sortino Ratio

RGEN:

-0.71

USA:

1.79

Omega Ratio

RGEN:

0.92

USA:

1.22

Calmar Ratio

RGEN:

-0.46

USA:

2.18

Martin Ratio

RGEN:

-1.06

USA:

7.07

Ulcer Index

RGEN:

27.37%

USA:

2.47%

Daily Std Dev

RGEN:

47.49%

USA:

13.96%

Max Drawdown

RGEN:

-98.28%

USA:

-69.06%

Current Drawdown

RGEN:

-55.05%

USA:

-1.67%

Fundamentals

Returns By Period

In the year-to-date period, RGEN achieves a 1.24% return, which is significantly lower than USA's 4.00% return. Over the past 10 years, RGEN has outperformed USA with an annualized return of 19.44%, while USA has yielded a comparatively lower 12.78% annualized return.


RGEN

YTD

1.24%

1M

-8.03%

6M

-9.10%

1Y

-26.57%

5Y*

6.60%

10Y*

19.44%

USA

YTD

4.00%

1M

5.22%

6M

10.25%

1Y

18.73%

5Y*

11.04%

10Y*

12.78%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RGEN vs. USA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RGEN
The Risk-Adjusted Performance Rank of RGEN is 1818
Overall Rank
The Sharpe Ratio Rank of RGEN is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of RGEN is 1616
Sortino Ratio Rank
The Omega Ratio Rank of RGEN is 1717
Omega Ratio Rank
The Calmar Ratio Rank of RGEN is 1919
Calmar Ratio Rank
The Martin Ratio Rank of RGEN is 2121
Martin Ratio Rank

USA
The Risk-Adjusted Performance Rank of USA is 8282
Overall Rank
The Sharpe Ratio Rank of USA is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of USA is 7676
Sortino Ratio Rank
The Omega Ratio Rank of USA is 7373
Omega Ratio Rank
The Calmar Ratio Rank of USA is 9191
Calmar Ratio Rank
The Martin Ratio Rank of USA is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RGEN vs. USA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Repligen Corporation (RGEN) and Liberty All-Star Equity Fund (USA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RGEN, currently valued at -0.61, compared to the broader market-2.000.002.004.00-0.611.25
The chart of Sortino ratio for RGEN, currently valued at -0.71, compared to the broader market-6.00-4.00-2.000.002.004.00-0.711.79
The chart of Omega ratio for RGEN, currently valued at 0.92, compared to the broader market0.501.001.502.000.921.22
The chart of Calmar ratio for RGEN, currently valued at -0.46, compared to the broader market0.002.004.006.00-0.462.18
The chart of Martin ratio for RGEN, currently valued at -1.06, compared to the broader market0.0010.0020.0030.00-1.067.07
RGEN
USA

The current RGEN Sharpe Ratio is -0.61, which is lower than the USA Sharpe Ratio of 1.25. The chart below compares the historical Sharpe Ratios of RGEN and USA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.61
1.25
RGEN
USA

Dividends

RGEN vs. USA - Dividend Comparison

RGEN has not paid dividends to shareholders, while USA's dividend yield for the trailing twelve months is around 10.06%.


TTM20242023202220212020201920182017201620152014
RGEN
Repligen Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
USA
Liberty All-Star Equity Fund
10.06%10.22%9.56%12.11%9.67%9.26%9.88%12.81%9.01%9.43%9.66%6.61%

Drawdowns

RGEN vs. USA - Drawdown Comparison

The maximum RGEN drawdown since its inception was -98.28%, which is greater than USA's maximum drawdown of -69.06%. Use the drawdown chart below to compare losses from any high point for RGEN and USA. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-55.05%
-1.67%
RGEN
USA

Volatility

RGEN vs. USA - Volatility Comparison

Repligen Corporation (RGEN) has a higher volatility of 10.58% compared to Liberty All-Star Equity Fund (USA) at 3.77%. This indicates that RGEN's price experiences larger fluctuations and is considered to be riskier than USA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
10.58%
3.77%
RGEN
USA

Financials

RGEN vs. USA - Financials Comparison

This section allows you to compare key financial metrics between Repligen Corporation and Liberty All-Star Equity Fund. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab